Nova Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Nova Financial's RXRX Position: Q3 2026 in Review
Nova Financial opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 772 shares worth $3.19K. The stake represents ﹤0.01% of the portfolio and ranks #714 among its holdings.
347 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Nova Financial held 772 shares of Recursion Pharmaceuticals worth $3.19K as of Q3 2026.
- Recursion Pharmaceuticals was a new Nova Financial position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #714 holding.
- 347 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.